Upregulation of NEK2 is associated with drug resistance in ovarian cancer

Oncology Reports
Xia LiuFuqiang Yin

Abstract

NEK2 [NIMA (never in mitosis gene A)-related expressed kinase 2] is associated with various biological behaviors in the development of cancer, while research concerning its association with drug resistance is limited. The association of NEK2 with drug resistance in ovarian cancer has not yet been reported. In the present study, on the basis of microarray results from Oncomine and the GEO Profiles online database, we revealed that NEK2 mRNA expression in ovarian cancer tissues is upregulated. In addition, its expression in drug-resistant ovarian cancer cells was upregulated when compared with expression with their sensitive or parental counterparts. Finally, we performed a comprehensive bioinformatic analysis consisting of protein/gene-protein/gene interaction network, annotation of biological processes and microRNA-mRNA interaction analysis. We observed that NEK2 directly or indirectly interacts with a number of genes, proteins, microRNAs and biological processes associated with drug resistance in ovarian and other types of cancer. These results indicate that NEK2 contributes to drug resistance in ovarian cancer and it may be an important therapeutic target.

References

Jan 24, 1997·Cell·R ScullyD M Livingston
Apr 14, 1999·CA: a Cancer Journal for Clinicians·S H LandisP A Wingo
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
Apr 8, 2004·Neoplasia : an International Journal for Oncology Research·Daniel R RhodesArul M Chinnaiyan
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Feb 8, 2005·Biochemical and Biophysical Research Communications·Peilin ZhangFei Chen
Jul 13, 2005·Cell·Carlo M Croce, George A Calin
Aug 31, 2006·Methods in Enzymology·Tanya Barrett, Ron Edgar
Oct 3, 2006·Developmental Cell·Wigard P Kloosterman, Ronald H A Plasterk
Nov 23, 2006·Trends in Molecular Medicine·Benjamin BarréOlivier Coqueret
Mar 14, 2007·Molecular Systems Biology·Roded SharanRon Shamir
Mar 27, 2007·Cold Spring Harbor Symposia on Quantitative Biology·I Behm-AnsmantE Izaurralde
Oct 13, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T Fojo, M Menefee
Oct 12, 2007·Future Oncology·Esmerina TiliGeorge Adrian Calin
Jan 10, 2008·International Journal of Cancer. Journal International Du Cancer·Rosalind C Gregory-BassWinston E Thompson
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Oct 1, 2008·Gynecologic Oncology·Antonio SorrentinoCristiano Ferlini
Jul 9, 2009·Molecular Cancer Research : MCR·Fan ZhangPaul R Andreassen
Nov 20, 2009·Gynecologic Oncology·Veronika AunerRobert Zeillinger
Jan 7, 2010·Journal of Oncology·Noriyuki Takai, Hisashi Narahara
Feb 11, 2010·Cancer Research·Lorenzo GalluzziGuido Kroemer
Mar 30, 2010·Cancer Science·Kazushi SuzukiMichinari Hamaguchi
Dec 8, 2010·Biometrics·Xiaoyu JiangEric D Kolaczyk
Jan 29, 2011·Cell Death and Differentiation·Y HuangE Ratovitski
May 17, 2011·Cancer Research·Euan A StronachHani Gabra
May 25, 2011·Journal of Biomedical Informatics·Harsh DweepNorbert Gretz

❮ Previous
Next ❯

Citations

Dec 9, 2014·BioMed Research International·Zhimin GuFenghuang Zhan
Aug 1, 2015·Journal of Ovarian Research·Sheng-Yun CaiMing-Juan Xu
Oct 15, 2014·BioMed Research International·Lingyao MengDavid J Bearss
Feb 24, 2015·BioMed Research International·Jiliang XiaFenghuang Zhan
Apr 26, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xinwen ZhongLin Zhang
Jun 28, 2014·International Journal of Oncology·Xia LiuFuqiang Yin
Sep 5, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mei-Xia ZhangZhi-Xiong Long
Nov 23, 2018·BMC Cancer·Chunyan GuSiegfried Janz
Nov 12, 2016·Oncotarget·Christopher R CoxonCéline Cano
Aug 5, 2015·Journal of Gastroenterology and Hepatology·Gizachew Y WubetuSatoru Imura
Jun 15, 2018·Molecular Medicine Reports·Xia LiuFuqiang Yin
Jul 20, 2019·Journal of Experimental & Clinical Cancer Research : CR·Ling DengDehua Wu
Sep 4, 2020·Cancers·Anna Vidal, Torben Redmer
Jan 20, 2017·International Journal of Oncology·Gang LiMin He
Dec 31, 2016·International Journal of Oncology·Fen ZhouYao Wang
Nov 21, 2017·Journal of Cellular Physiology·Leyla Norouzi-BaroughRasoul Salehi
Jun 5, 2018·The Journal of Clinical Investigation·Reinaldo Franqui-MachinFenghuang Zhan
Apr 22, 2015·International Journal of Oncology·Xia LiuFuqiang Yin
Mar 29, 2016·Cell Cycle·Yanfen Fang, Xiongwen Zhang
Nov 18, 2020·Journal of Physiology and Biochemistry·Hao WanTaiyuan Li
Apr 12, 2020·Trends in Molecular Medicine·Andrea RemoMassimo Pancione

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Baosheng WangYi Zhao
Biochemical and Biophysical Research Communications
Matthieu SchoenhalsBernard Klein
Biochemical and Biophysical Research Communications
Jérôme MoreauxBernard Klein
© 2021 Meta ULC. All rights reserved